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The hematopoietic colony stimulating factor-1
receptor (CSF-1R or FMS) is essential for the cellular
repertoire of the mammalian immune system. Here,
we report a structural and mechanistic consensus
for the assembly of human and mouse CSF-1:CSF-
1R complexes. The EM structure of the complete
extracellular assembly of the human CSF-1:CSF-1R
complex reveals how receptor dimerization by
CSF-1 invokes a ternary complex featuring extensive
homotypic receptor contacts and striking structural
plasticity at the extremities of the complex. Studies
by small-angle X-ray scattering of unliganded
hCSF-1R point to large domain rearrangements
upon CSF-1 binding, and provide structural evidence
for the relevance of receptor predimerization at the
cell surface. Comparative structural and binding
studies aiming to dissect the assembly principles of
human and mouse CSF-1R complexes, including
a quantification of the CSF-1/CSF-1R species
cross-reactivity, show that bivalent cytokine binding
to receptor coupled to ensuing receptor-receptor
interactions are common denominators in extracel-
lular complex formation.
INTRODUCTION
Receptor tyrosine kinases (RTKs) are a large family of metazoan-
specific cell surface receptors that play essential roles in diverse
cellular processes (Lemmon and Schlessinger, 2010). The hall-
mark of signaling via RTKs lies in cytokine-induced activation
of the receptor extracellular segments, which initiates a cascade
of intracellular signaling following activation of the intrinsic tyro-
sine kinase activity of RTKs. Class III RTK (RTKIII) groups four
pleiotropic hematopoietic receptors: the prototypic platelet-
derived growth factor receptor (PDGFR), colony stimulating1762 Structure 19, 1762–1772, December 7, 2011 ª2011 Elsevier Ltdfactor-1 receptor (CSF-1R), KIT, and fms-like tyrosine kinase III
receptor (Flt3). Collectively, intracellular signaling via RTKIII has
a major impact in the development and homeostasis of the
cellular repertoire throughout the hematopoietic system. RTKIIIs
are characterized by a modular structure featuring five extracel-
lular Ig-like domains followed by a single transmembrane helix
(TM) and intracellular split kinase domains (Lemmon and Schles-
singer, 2010). A remarkable aspect of RTKIII activation is that the
cognate protein ligands are all dimeric with similar dimensions
despite their grouping into two fundamentally different folds
(four helix bundles versus all-b cystine-knot scaffolds) (Jiang
et al., 2000; Oefner et al., 1992; Pandit et al., 1992; Savvides
et al., 2000; Wiesmann et al., 1997; Zhang et al., 2000). Recently,
interleukin-34 (IL-34) was identified as a second ligand to
CSF-1R (Lin et al., 2008), thus adding a perplexing dimension
to RTKIII signaling because IL-34 bears no sequence similarity
to the currently known cytokine ligands for RTKIII/V or other
proteins.
Activation of the extracellular segment of human CSF-1R
(hCSF-1R) by its two cytokine ligands, hCSF-1 and IL-34, is
the cornerstone of signaling cascades central to immunity
because CSF-1R:cytokine-signaling complexes are essential
for the proliferation, differentiation, and functionality of cells
derived from the mononuclear phagocytic lineage, such as
monocytes, tissue macrophages, microglia, osteoclasts, and
antigen-presenting dendritic cells (Chihara et al., 2010; Chitu
and Stanley, 2006; Lin et al., 2008;Wei et al., 2010). Furthermore,
signaling via wild-type hCSF-1R and mutants thereof has been
implicated in a wide range of pathologies in humans, such as
arthritis, atherosclerosis, tumor growth, and metastasis (Chitu
and Stanley, 2006).
CSF-1R is arguably the most intriguing member of the RTKIII
family for two main reasons: (i) CSF-1R is the only known RTK
that is activated by two unrelated protein ligands, and (ii)
CSF-1R activation demonstrates restrictive species specificity.
For instance mouse CSF-1 (mCSF-1) does not signal through
hCSF-1R and other primate CSF-1Rs, yet, hCSF-1 can activate
CSF-1R from all primate and nonprimate species tested thus far
(Garceau et al., 2010). IL-34, the recently identified second
ligand for CSF-1R, appears to follow suit, in that human IL-34All rights reserved
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Assembly Principles of CSF-1R Ectodomain Complexesdoes not activate mCSF-1R, whereas murine IL-34 does signal
through hCSF-1R (Wei et al., 2010).
Despite the prominence of hCSF-1R and hCSF-1 in the
biomedical literature over the last 3 decades, structural charac-
terization of the extracellular complex has remained elusive,
whereas structures of the intracellular kinase domain have only
recently become available (Schubert et al., 2007; Walter et al.,
2007). Such insights are the missing link to the structural and
functional diversity of RTKIII/V extracellular complexes, and
would help provide a nearly complete picture of the entire
CSF-1 ligand-receptor signaling complex given the available
structure of the CSF-1R intracellular kinase domains. A recent
flurry of studies of RTKIII/V extracellular complexes led to a
structural paradigm for RTKIII/V activation, whereby the recep-
tors bind via their N-terminal Ig-like domains to the activating
dimeric cytokine and concomitantly make homotypic contacts
between their membrane-proximal domains (Chen et al., 2008;
Leppa¨nen et al., 2010; Liu et al., 2007; Ruch et al., 2007; Shim
et al., 2010; Verstraete et al., 2011b; Yang et al., 2008, 2010;
Yuzawa et al., 2007).
A recent structural study of mCSF-1 in complex with the first
three extracellular domains of mCSF-1R (mCSF-1RD1–D3)
revealed unexpected monovalent binding of mCSF-1 to one
mCSF-1RD1–D3 molecule leading to a binary complex (Chen
et al., 2008), in contrast to predictions based on earlier studies
of the homologous murine and human c-kit receptors in complex
with stem cell factor (SCF). Although this first structural snapshot
of a partial mCSF-1R complex is informative in its own right, it
cannot be readily extrapolated to represent CSF-1R activation
in general, given the complexity of species cross-reactivity in
CSF-1R signaling. Furthermore, the reported binary mCSF-
1RD1–D3:mCSF-1 complex does not offer realistic insights into
possible homotypic receptor interactions, a likely critical element
of receptor activation.
Here, we dissect the structural modularity and thermo-
dynamic-binding fingerprints of the extracellular human and
mCSF-1:CSF-1R assemblies. Together, our comparative
studies provide a comprehensive set of structural and mecha-
nistic insights that now helps to establish a consensus for the
assembly of hematopoietic CSF-1 ligand-receptor complexes.
RESULTS AND DISCUSSION
Biochemical and Thermodynamic Characterization
of Full-Length CSF-1R Ectodomain Complexes
(CSF-1:CSF-1RD1–D5)
To enable structural and biophysical studies of human and
mCSF-1:CSF-1RD1–D5 complexes, we produced recombinant
glycosylated human and mouse CSF-1RD1–D5 in transiently
transfected HEK293T cells in the presence of kifunensine, which
limits N-linked glycosylation to Man5–9GlcNAc2 glycan struc-
tures (Chang et al., 2007). Recombinant human and mouse
CSF-1 was produced by in vitro refolding of inclusion bodies
after protein expression in E. coli. Preparations of purified re-
combinant hCSF-1 and glycosylated hCSF-1RD1–D5 were analyt-
ically fractionated by field-flow fractionation (FFF), followed
by quantification of their molecular weight (MW) via online
multi-angle laser light scattering (MALLS). This led to MW deter-
minations of 35 and 76 kDa, for hCSF-1 and hCSF-1RD1–D5,Structure 19, 1762–17respectively. These values are in excellent agreement with the
electrophoretic mobility of dimeric hCSF-1 and monomeric gly-
cosylated hCSF-1RD1–D5 on SDS-PAGE (Figure 1A). Titration of
hCSF-1RD1–D5 with excess molar amounts of cognate CSF-1 re-
sulted in a monodisperse molecular species that exhibited a
marked shift in elution profile to a much larger particle (145 kDa
as determined by MALLS) when compared to the unbound
CSF-1R ectodomain (Figure 1A). Considering the experimental
accuracy of MW determination by MALLS, we could infer that
the apparent CSF-1:CSF-1RD1–D5 complex could be rationalized
in terms of one hCSF-1 dimer and two copies of hCSF-1RD1–D5.
We employed isothermal titration calorimetry (ITC) to establish
the affinity, thermodynamic profile, and stoichiometry of the
CSF-1:CSF-1RD1–D5 complex. Our results show that the com-
plex is characterized by bivalent binding of hCSF-1 to the
receptor ectodomain (one hCSF-1 dimer to two molecules of
hCSF-1RD1–D5) and that the ensuing high-affinity complex (equi-
librium dissociation constant [KD] = 13.6 nM) is the result of
a markedly exothermic binding event coupled to an entropic
penalty (Figure 1B; see Table S2 available online). The nanomolar
(nM) affinity value we report here for the soluble full-length extra-
cellular complex differs significantly from previously reported KD
values of 50–100 pM for native hCSF-1R based on cell assays
(Roussel et al., 1988). Similar differences have already been
observed for a number of systems, including the homologous
KIT and Flt3 (Graddis et al., 1998; Lemmon et al., 1997; Lev
et al., 1992; Streeter et al., 2001; Verstraete et al., 2011b), and
can be attributed to the absence of the TM region and the
two-dimensional spatial confinement of the membrane. Upon
extending our analysis to the mCSF-1:CSF-1R ectodomain
complex, we found that mCSF-1 also binds its cognate mCSF-
1RD1–D5 in a bivalent fashion to form a high-affinity ternary
complex (KD = 21.7 nM) (Figure 1B) with a similar thermodynamic
profile, indicating that the assembly of human and mouse ecto-
domain complexes is likely based on common principles.
Characterization of the CSF-1 Ligand-Receptor
Species Cross-Reactivity
We took advantage of the availability of human andmouse extra-
cellular CSF-1Rs and ligands to quantify their cross-reactivity
and to lend further cross-validation to the binding stoichiome-
tries determined for the human and mouse complexes. To our
knowledge, this has never been reported while the biomedical
literature is heavily populated by studies of hCSF-1 activity in
a murine cellular background and vice versa. Such information
could have important implications in the design and interpreta-
tion of cellular assays testing cytokine:receptor activity from
a particular species in a heterologous background. Our experi-
ments revealed bivalent binding of CSF-1 ligands to receptors
in both cross-reactivity experiments, consistent with the binding
behavior of human and mCSF-1R to their cognate ligands
(Figure 2). We calculated a KD of 66.2 nM for the hCSF-
1:mCSF-1RD1–D5 interaction, which agrees well with the ability
of hCSF-1 to activate all nonprimate CSF-1R tested so far. On
the other hand, mCSF-1 binds nearly 500-fold less tightly to
hCSF-1RD1–D5 (KD = 2.8 mM) than to its cognate receptor, thus
corroborating the observation thatmCSF-1 is not able to activate
primate CSF-1R in a cellular setting (Figure 2). Together, our
binding studies on the assembly of cognate and noncognate72, December 7, 2011 ª2011 Elsevier Ltd All rights reserved 1763
Figure 1. hCSF-1RD1–D5 Forms a Ternary Assembly with hCSF-1
(A) Isolation of hCSF-1RD1–D5:hCSF-1 by FFF. Formation of the complex leads to a marked shift in elution profile away from the individual protein components
after titration with a molar excess of hCSF-1. The different protein components employed are annotated. The inset shows an SDS-PAGE strip of the isolated
complex. The disulfide-linked dimeric nature of hCSF-1 is confirmed because the samples are lacking BME. Slight smearing of the hCSF-1RD1–D5 band is due to
a certain level of heterogeneous glycosylation (Aricescu et al., 2006). The insets show molecular mass determination by MALLS. The measurements confirm the
dimeric nature of hCSF-1 and suggest a hCSF-1RD1–D5monomer and a hCSF-1:hCSF-1RD1–D5 1:2 stoichiometry of binding. Derivedmolecular masses and fits to
the experimental LS data are shown.
(B) Titration of hCSF-1 into hCSF-1RD1–D5 (left panel) and mCSF-1 into mCSF-1RD1–D5 (right panel). Both CSF-1 ligands form a high-affinity ternary complex (n =
1:2) with their cognate receptors.
Structure
Assembly Principles of CSF-1R Ectodomain ComplexesCSF-1 ligand-receptor complexes show that bivalent cytokine
binding to receptor is a conserved mechanistic aspect of the
extracellular ligand-receptor interaction.
Electron Microscopy Structure of the Complete
Extracellular Assembly of the hCSF-1:CSF-1R Complex
We approached structural characterization of the complete
extracellular-signaling complex of hCSF-1R with hCSF-1, based
on images of negatively stained hCSF-1RD1–D5:hCSF-1 complex
obtained by electron microscopy (EM). The recombinant hCSF-
1RD1–D5:hCSF-1 complex used in the EM analysis was obtained
by preparative size-exclusion chromatography (SEC) as a highly
monodisperse molecular species. Multivariate statistical anal-
ysis (MSA) and classification of circa 18,500 particles indicated
the presence of a 2-fold symmetry axis. Thus, an ab initio 3D
reconstruction was produced by angular reconstitution with
imposed C2 symmetry and further improved by iterative
projection matching to generate a 3D reconstruction of the
hCSF-1RD1–D5:hCSF-1 extracellular complex to23 A˚ resolution
(Figures 3A and 3B).
The reconstructed 3D molecular envelope of the hCSF-1RD1–
D5:hCSF-1 complex reveals a central triangular toroidal structure
featuring a pair of appendages extending away from each other
at the top of the ring in a plane perpendicular to the toroid,
and two in-plane legs of electron density emanating from the
bottom of the ring (Figure 3B). Clear features in the electron
density strongly suggested that dimeric hCSF-1 binds bivalently
to two hCSF-1RD1–D5 receptor molecules at the head of the
particle, and that the two receptor molecules engage in homo-
typic interactions away from the ligand-binding epitope. Manual1764 Structure 19, 1762–1772, December 7, 2011 ª2011 Elsevier Ltdplacement of homology models of hCSF-1RD1–D5 derived from
the structure of the extracellular segment of human KIT (Yuzawa
et al., 2007), and of the crystal structure of hCSF-1 (Pandit et al.,
1992), into the EM map confirmed this initial interpretation, and
showed that the volume of the EM map could readily account
for all components of the hCSF-1R extracellular complex. To
improve our preliminary model against the experimental EM
envelope, we employed a computational approach based on
molecular dynamics protocols, which produced 20 different
models that were subsequently averaged to yield the final model
(Figure 3B; Figure S1A).
The hCSF-1RD1–D5:hCSF-1 complex now joins the human
KITD1–D5-SCF (Yuzawa et al., 2007) and the human Flt3 ligand-
receptor (Verstraete et al., 2011b) complexes as the third
complete extracellular RTKIII complex structurally characterized
to date, and offers important architectural and functional
insights. First, it reveals that the cytokine-binding epitope on
hCSF-1R is defined by domains 2 and 3 (Figure 3B). With the
exception of the Flt3 ligand-receptor interaction, this feature of
receptor-ligand engagement has emerged as a consensus blue-
print of RTKIII activation in all other structurally characterized
RTKIII complexes thus far (binary mCSF-1RD1–D3:mCSF-1
complex, Chen et al., 2008; KITD1–D3(5):SCF, Liu et al., 2007;
Yuzawa et al., 2007; and PDGFRD1–D3:PDGF-B, Shim et al.,
2010). Second, it shows that receptor homotypic interactions
can be attributed to a broad interaction interface between the
tandem D4 domains of hCSF-1R, whereas the membrane-prox-
imal D5 domains diverge away to a separation of 65 A˚ (Fig-
ure 3B). Homotypic receptor interactions have long been consid-
ered as the driving force for the cooperative character ofAll rights reserved
Figure 2. Thermodynamic Characterization
of Noncognate Extracellular Human and
Mouse CSF-1 Receptor-Ligand Complexes
Thermodynamic measurements of the human
and mouse CSF-1RD1–D5:CSF-1 species cross-
reactivity. In each case CSF-1 was titrated into
noncognate CSF-1R. hCSF-1 is able to form a
high-affinity complex with mCSF-1R D1–D5 (left
panel), whereas the mCSF-1:hCSF-1RD1–D5 inter-
action is of much lower strength (right panel). Both
complexes display a 1:2 CSF-1:CSF-1R stoichi-
ometry of binding.
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Assembly Principles of CSF-1R Ectodomain Complexesextracellular complex formation and activation in RTK. Recent
studies on RTKIII receptors KIT and PDGFR showed that
receptor contacts mediated by a conserved dimerization
sequence fingerprint mapped to the EF loop of D4 are important
for receptor activation (Yang et al., 2008; Yuzawa et al., 2007)
(Figure 3C). Consistent with the proposed key role of the
consensus dimerization motif, structural studies on Flt3, the
only RTKIII/V receptor lacking this sequence fingerprint, showed
that the Flt3 ligand-receptor assembly is devoid of homotypic
receptor interactions (Verstraete et al., 2011b).
Whereas our structural studies show that hCSF-1RD4 plays
a direct role in the CSF-1 extracellular ternary complex, the
possible contribution of D5 still remains unclear. The
membrane-proximal D5 in KITD1–D5-SCF does not make interac-
tions with its tandem D5 and the corresponding C termini come
to 15 A˚ from each other (Yuzawa et al., 2007). Furthermore, the
crystal structure of the complete extracellular Flt3 ligand-
receptor complex has recently shown that the two Flt3D5
approach each other to about 25 A˚ (Verstraete et al., 2011b). In
hCSF-1R this separation is much larger, thus highlighting the
possible conformational diversity of the membrane-proximal
domains. Reconciling such interdomain distances in terms of
growing evidence on the importance of TM domains in RTK acti-
vation (Finger et al., 2009; Li and Hristova, 2006) is not obvious.
Yet, it would appear that the linker regions between D5 and the
TM domains of RTKIII (typically 10–15 amino acids) would offer
the necessary spatial freedom to allow such intramembrane
interactions to take place, whereas the D4–D5 interface could
help orient such associations. Finally, our studies show that
the N-terminal D1 extends well away from the core of the
complex without making any interactions with the ligand or other
receptor domains. Our computational models show consider-
able rigid-body flexibility around the D1–D2 linker (Figure S1A).Structure 19, 1762–1772, December 7, 2011 ªIndeed, the corresponding negative-stain
electron density for D1 only became clear
in later rounds of image classification.
Interestingly, Flt3D1 in the Flt3 ligand-
receptor complex also emanates away
from the core of the complex (Verstraete
et al., 2011b). It is currently not clear
what the possible role of such flexible
D1 modules might be, but it has been
suggested that D1 might participate in
intermolecular interactions at the cell
surface (Verstraete et al., 2011b).However, the apparent conformational independence of D1 in
human Flt3 and CSF-1R is not a conserved structural feature
within the RTKIII family because structures of the binary
mCSF-1RD1–D3:mCSF-1 complex, as well as the ternary
KITD1–D3(5):SCF and PDGFRD1–D3:PDGF-B complexes, shows
that D1 bends downward to interact with D2. We carried out
additional measurements on hCSF-1RD1–D5:hCSF-1 by small-
angle X-ray scattering (SAXS), which consistently corroborate
our EM findings, in that the scattering data indicate a P2-
symmetric ternary complex with flexible D1 and large divergence
of the membrane-proximal D5 (Figure S1B; Table S1).
Structural Plasticity of hCSF-1RD1–D5 Revealed by SAXS
Analysis of the Unbound Receptor
We carried out measurements on hCSF-1RD1–D5 by SAXS to
generate structural insights into unbound hCSF-1R and any
possible domain rearrangements that might occur upon ligand
binding. The X-ray scattering by hCSF-1RD1–D5 within a broad
concentration range was only consistent with a dimeric species
(Figure 4; Table S1). Interestingly, the MW for hCSF-1RD1–D5 as
determined based on our SAXS data is exactly twice the MW
determined via analytical FFF-MALLS measurements conduct-
ed at lower concentrations (Figure 1A). This suggests that
monomeric and dimeric species for hCSF-1RD1–D5 can exist in
equilibrium, albeit with a rather poor KD. Molecular envelopes
derived from ab initio reconstructions and rigid-body modeling
agree remarkably well with each other and point to awell-defined
dimeric assembly that lacks internal symmetry (Figure 4).
Despite the dramatic deviation from the 2-fold symmetry
observed in the receptor:ligand complex (Figure 3B), we note
that the extended conformation of the unliganded receptor
resembles the bound conformation observed in the EM struc-
ture, hinting that preferential structural sampling might facilitate2011 Elsevier Ltd All rights reserved 1765
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Figure 3. Architecture of Liganded hCSF-1RD1–D5
(A) Three-dimensional reconstruction of the hCSF-1RD1–D5:hCSF-1 complex fromEMdata. A gallery of representative class averages (above) and reprojections of
the final 3D reconstruction (below) under similar orientations is shown.
(B) Angle, front, top, and side orientational views of the reconstructed particle superimposed with computational models of the complex.
(C) Conservation of the D4-D40 dimerizationmotif acrossmembers of the RTKIII and RTKV families. Residues 374–393 present on the D4 bE strand and EF loop of
hKIT are alignedwith corresponding sequences of h/mCSF-1R, hFlt3, hPDGFR, and hVEGFR. Conserved residues are highlighted. hFlt3 lacks the completemotif
and has been shown to be devoid of homotypic receptor contacts (Verstraete et al., 2011).
See also Figure S1.
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Assembly Principles of CSF-1R Ectodomain Complexesproductive ligand binding. The observed hCSF-1R dimerization
in vitro is consistent with previously reported cellular studies
that showed the propensity of CSF-1R to form dimers at the
cell surface of CSF-1-dependent BAC1.2F5 cells (Li and Stanley,
1991). Thus, the structural view of unbound hCSF-1R analysis of
the SAXS data may represent dimeric forms of hCSF-1R at high
levels of receptor expression or when the receptors are constitu-
tively activated in disease scenarios. In this respect extracellular
receptor predimerization could also play an important role in
generating the ultrahigh affinities observed in a physiological
setting. Interestingly, a number of other RTKs, such as the
IGF1 (Lawrence et al., 2007), EGFR (Chung et al., 2010; Mi
et al., 2011), and Eph (Himanen et al., 2007) receptors, do form
oligomers in the absence of cytokine ligand. Nonetheless,
hCSF-1RD1–D5 would have to undergo dramatic domain rear-
rangements to bind hCSF-1. Such conformational switching
has already been observed in the related human KIT (Yuzawa
et al., 2007) and human VEGFR (Ruch et al., 2007). Together,
our data reinforce the notion that extracellular complex forma-
tion is cooperative and relies on an intricate interplay of
receptor-ligand interactions, and intramolecular and homotypic
receptor contacts.
Human and Mouse CSF-1RD1–D3 Can Form Stable
Ternary Complexes with Cognate CSF-1 Ligands
A previous structural study of mCSF-1 in complex with the first
three extracellular domains of mCSF-1R (mCSF-1RD1–D3)
revealed an unexpected binary complex, whereby a mCSF-1
dimer binds monovalently to a single mCSF-1RD1–D3 molecule
(Chen et al., 2008). This is in striking contrast to full-length ecto-
domain that forms a ternary complex with cognate or noncog-
nate ligand (Figures 1–3). To address this apparent discrepancy
in behavior between full-length and truncated receptors and to
explore the contribution of the D4–D5 module to the mechanism1766 Structure 19, 1762–1772, December 7, 2011 ª2011 Elsevier Ltdof ternary complex formation, we produced recombinant glyco-
sylated human and mCSF-1RD1–D3 to enable structural and
biophysical studies.
Although the full-length ectodomains could readily reach their
endpoint assembly even with substoichiometric molar amounts
of hCSF-1 using either SEC or FFF methods (Figure 1A), the
CSF-1RD1–D3 constructs behaved differently (Figure 5). Titrating
hCSF-1with amolar excess of hCSF-1RD1–D3 only leads tominor
shift on SEC as a shoulder peak of the unbound CSF-1RD1–D3
peak (Figure 5A). This behavior is consistent with previous find-
ings (Chen et al., 2008). However, upon titrating hCSF-1RD1–D3
with a stoichiometric excess of cytokine ligand, a clear shift
can be obtained in the elution profile of hCSF-1RD1–D3 on SEC
corresponding to a well-defined and markedly larger molecular
species (Figure 5A). We sought to obtain more direct evidence
into the molecular composition of the two species observed in
SEC by attempting to determine their MW via analytical FFF-
MALLS. Preparation of the hCSF-1:hCSF-1RD1–D3 complex by
either a molar excess of hCSF-1 or hCSF-1RD1–D3 consistently
revealed an 65 kDa assembly, consistent with binary complex
formation (Figure 5B). This clearly contradicted the chromato-
graphic observation of two different kinds of complexes via
SEC (Figure 5A). In an effort to resolve this apparent discrep-
ancy, we applied the peak fraction obtained via SEC by titrating
a molar excess of hCSF-1 to hCSF-1RD1–D3 to FFF followed by
MALLS measurements. This fraction falls apart into two peaks,
and the largest molecular species represented a 65 kDa particle
as determined by MALLS (Figure 6A). Therefore, we wondered
whether the kinetics of molecular diffusion underlying the FFF
method combined with a possible instability of the hCSF-
1:hCSF-1RD1–D3 at such low concentrations might affect the
integrity of the complex. To address this, we first subjected
the distinct peak of the hCSF-1:hCSF-1RD1–D3 complex isolated
by SEC (Figure 5A) to crosslinking with formaldehyde followedAll rights reserved
Figure 4. Plasticity of Unliganded hCSF-1RD1–D5
Structural analysis of unliganded hCSF-1RD1–D5 by SAXS.
Experimental scattering curves are shown in black to
a maximal momentum transfer of s = 0.25 A˚1 (nominal
resolution 25 A˚), and the individual data:fit pairs are put on
an arbitrary y axis to allow for better visualization. Curve ‘‘i’’
shows rigid-body optimized fit of dimeric hCSF-1RD1–D5.
Modeling was constrained by specifying ambiguous
contact distances for the D4–D5 and D40–D50 modules
(circled). Curve ‘‘ii’’ shows rigid-body optimized fit of
receptor domains for monomeric hCSF-1RD1–D5. The
upper inset shows the calculated distance distribution
function for modeled dimeric and monomeric receptors,
and their fits with the experimental function. The rigid-
body SASREF model and ab initio GASBOR bead model
are displayed side to side to highlight agreement in overall
shape reconstruction. See also Table S1.
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Assembly Principles of CSF-1R Ectodomain Complexesby fractionation via FFF and MALLS measurements. Indeed, this
approach led to a dramatically different elution profile on FFF
characterized by a single peak corresponding to a molecular
species of 109 kDa (Figure 6A). This indicates that both binary
and ternary hCSF-1:hCSF-1RD1–D3 complexes are possible de-
pending on experimental conditions, and that an apparent
prerequisite for the formation and stability of the ternary complex
is the presence of a stoichiometric excess of ligand.
We employed ITC to further characterize the interaction
between hCSF-1RD1–D3 with cognate hCSF-1 and to obtain
insights into the contribution of the membrane-proximal module
D4–D5 to the extracellular assembly (Figure 6B). First, the
binding isotherm could be accurately fitted using a ‘‘one set of
binding sites’’ model, and there was no evidence for two sequen-
tial or independent binding sites with different affinities. Impor-
tantly, the complex displayed a 1:2 stoichiometry of binding
revealing bivalent binding of hCSF-1 to hCSF-1RD1–D3, in
complete agreement with the association mode of the full-length
ectodomain complex (Figure 1B). Nonetheless, the strength of
the interaction and the corresponding thermodynamic profile
differs drastically from that of the hCSF-1RD1–D5:hCSF-1 interac-
tion (Figure 6B; Table S2). Notably, hCSF-1 binds 15-fold less
tightly to hCSF-1RD1–D3 than to full-length extracellular hCSF-
1R (KD = 213 nM versus KD = 13.6 nM). Thus, the absence of
the membrane-proximal module D4–D5 provides a significant
enthalpic loss of 15 kcal mol1 coupled to an entropic gain.
The observation of the bivalent hCSF-1RD1–D3:hCSF-1
complex via ITC (n = 0.5) is in stark contrast to the monovalent
binding mode reported for the mCSF-1RD1–D3:CSF-1 interaction
(Chen et al., 2008), thus creating a puzzling paradox with respect
to mechanistic aspects of receptor binding and activation. ItStructure 19, 1762–1772, December 7,would indeed seem unlikely that complex
formation would bear such fundamental differ-
ences in the two homologous systems given
the preponderance of conserved sequences
on human and mCSF-1 and CSF-1R involved
at the interaction epitope (Figure S2). To resolve
the apparent disagreement between the two
sets of findings, we characterized the assembly
of the mCSF-1:CSF-1RD1–D3 complex by ITC.
Our results based on several experimentalreplicas show unequivocally that the stoichiometry, corre-
sponding affinities, and thermodynamic profile for mCSF-
1RD1–D3:mCSF-1 are equivalent to those of the human counter-
part (Figure 6B). Furthermore, we conclude that the relative
contribution of the membrane-proximal domains to complex
formation is similar in the two systems indicating a conserved
role for the D4–D5 in the assembly of the extracellular complex.
Thus, both the human and mCSF-1 ligand-receptor assemblies
appear to share a common interaction mode, based on the
inherent capacity of CSF-1 to bind bivalently to its cognate
receptor. It is currently unclear why the ITC measurements by
Chen et al. (2008) on the mCSF-1RD1–D3:CSF-1 interaction
deviate so fundamentally from the data we present here.
Nonetheless, our combined SEC/FFF/MALLS analysis of the
CSF-1:CSF-1RD1–D3 complex provides a rationale for the crys-
tallographic observation of the intriguing mCSF-1:CSF-1RD1–D3
binary complex (Chen et al., 2008), in the sense that we have
shown that both ternary and binary assemblies can be formed
for the CSF-1:CSF-1RD1–D3 complex depending on experimental
conditions.
To provide further structural insights into extracellular complex
formation and to investigate further the bivalent mode of CSF-1
binding to CSF-1R revealed by our ITC analysis (Figure 6B), we
measured SAXS data for the hCSF-1RD1–D3:hCSF-1 and
mCSF-1RD1–D3:mCSF-1 complexes (Figure 6C; Table S1). Both
complexes were prepared via SEC by saturating CSF-1RD1–D3
with a molar excess of cognate CSF-1, and were conservatively
pooled (Figure 5A). Our data analysis reveals that the crystal
structure of the binary mCSF-1:mCSF-1RD1–D3 complex (Chen
et al., 2008) is grossly incompatible with the SAXS data (Fig-
ure 6C, curve i), thereby directly challenging the claim that2011 ª2011 Elsevier Ltd All rights reserved 1767
Figure 5. hCSF-1 Can Make Both a Monovalent and Bivalent Complex with hCSF-1RD1–D3
(A) Isolation of the hCSF-1RD1–D3:hCSF-1 complex by SEC. Titration with either a molar excess of hCSF-1RD1–D3 or hCSF-1 leads to different complexes. A
marked shift in elution profile away from the individual protein components can only be observed after titration with a molar excess of hCSF-1. The resulting peak
fraction has as such been analyzed by SAXS (Figure 6C). The different protein components employed are annotated.
(B) Only the binary complex can be observed by FFF, regardless of stoichiometric excess of any component.
Structure
Assembly Principles of CSF-1R Ectodomain ComplexesmCSF-1 cannot dimerize mCSF-1R in the absence of the
membrane-proximal module D4–D5 (Chen et al., 2008). Both
the molecular parameters obtained directly via SAXS and struc-
tural modeling of the data showed unambiguously that hCSF-
1RD1–D3:hCSF-1 and mCSF-1RD1–D3:mCSF-1 can form stable
ternary complexes with P2 symmetry in solution (Figure 6C,
curves ii–iii), thus providing a structural basis for the observed
binding stoichiometries via ITC (Figure 6B). Furthermore, we
note that the overall features of hCSF-1RD1–D3:hCSF-1 in solu-
tion are consistent with the corresponding segment in the
hCSF-1RD1–D5:hCSF-1 EM model, in that D1 points upward,
albeit at a slightly different angle (Figure 6C, curve iii).
A Common Assembly Mechanism for Human
and Mouse CSF-1 Ligand-Receptor Complexes
The integration of our findings on both the human and mouse
CSF-1 ligand-receptor complexes puts our study in position to
help resolve a puzzling mechanistic paradox for the assembly
of extracellular CSF-1 ligand-receptor complexes that arose
from a recent study on the mouse system (Chen et al., 2008).
The premise of this study was that mCSF-1 is unable to dimerize
its cognate receptor in the absence of the membrane-proximal
domains D4 and D5. The authors proposed that formation of
a binary complex lowers the affinity of the second binding site
on the dimeric cytokine, calling upon a ‘‘negative cooperativity’’
scenario, and extrapolated their reasoning to a distinct mecha-
nistic proposal for CSF-1R activation entailing two steps. In a first
step, the ligand and receptor form an initial binary complex with
low affinity that can only proceed to the ternary complex upon
the simultaneous formation of cytokine-receptor interactions at
the opposite binding epitope coupled to homotypic receptor
interactions.
The diverse biochemical and structural evidence we reported
here illustrates that the assembly of human and mouse extracel-1768 Structure 19, 1762–1772, December 7, 2011 ª2011 Elsevier Ltdlular CSF-1 complexes is driven by two common overriding prin-
ciples. In the first instance, the cytokine ligands have the inherent
capacity to offer two receptor binding sites leading to ternary
complex formation. Thus, bivalent binding of CSF-1 can take
place to the pool of monomeric and dimeric CSF-1R at the cell
surface. Second, assembly of the high-affinity complex is
dramatically enhanced as a result of well-defined homotypic
interactions between extracellular domain 4 modules. This is
an example of positive cooperativity, and in the case of CSF-1,
this is reflected in a pronounced enthalpy gain upon formation
of the ternary complex. This also implies that binding of cytokine
ligand to already predimerized CSF-1R would invoke a re-
orientation of the ectodomains to prime their role in the signaling
complex. Together, these two sequential steps constitute a clear
consensus for the binding events that lead to the assembly of
high-affinity human and mCSF-1 ligand-receptor complexes. It
remains to be seenwhether IL-34, the newly discovered cytokine
ligand for CSF-1R, will follow suit.
EXPERIMENTAL PROCEDURES
Production of Recombinant CSF-1 and CSF-1R Ectodomain Variants
and Complexes Thereof
Recombinant human and mCSF-1 were produced as inclusion bodies in
a prokaryotic expression system based on a previously described approach
(Verstraete et al., 2009) and were purified to homogeneity following in vitro
refolding. The fragment encoding residues 1–149 corresponding to the a splice
variant of human and mCSF-1 was cloned into the pET-15b vector (Novagen).
After expression in the BL21(DE3) CodonPlus-RP (Novagen) E. coli strain,
h/mCSF-1 accumulated as inclusion bodies. The inclusion bodies were
washed three times and then solubilized in 6.5 M GnHCl, 100 mM NaPO4
(pH 8.0), 10 mM Tris, and 10 mM b-mercaptoethanol (BME). Next, denatured
h/mCSF-1 was refolded by rapid dilution in refolding buffer (100 mM Tris
[pH 8.5], 1 M L-arginine, 3 mM GSH, 1.5 mM GSSG, and 0.2 mM PMSF) at
277 K. The clarified refoldingmixture was loaded onto a HisTrap FF 5ml affinity
column, eluted, and subsequently purified by SEC using a Prep-Grade HiLoadAll rights reserved
Figure 6. Human and Mouse CSF-1RD1–D3 Can Form Ternary Complexes with Cognate CSF-1 Ligands
(A) The ternary hCSF-1RD1–D3:hCSF-1 complex is transient on FFF. Injection of the isolated SEC peak fraction (Figure 5A) on FFF reveals a disassembly of the
complex. A 110 kDa species indicative of a ternary complex can only be observed after incubation with a crosslinking agent, suggesting that a ternary complex is
inherently less stable. The insets show an SDS-PAGE strip of the isolated noncrosslinked complex and molecular mass determination by MALLS.
(B) Thermodynamic profile of hCSF-1RD1–D3:hCSF-1 and mCSF-1RD1–D3:mCSF-1. Both thermograms can be accurately fitted by a ‘‘one set of binding sites’’
model and display a 1:2 CSF-1:CSF-1RD1–D3 stoichiometry of binding.
(C) Structural analysis of hCSF-1RD1–D3:hCSF-1 (left panel) and mCSF-1RD1–D3:mCSF-1 (right panel) by SAXS after isolation by SEC (Figure 5A). Experimental
scattering curves are shown in black to a maximal momentum transfer of s = 0.25 A˚1 (nominal resolution 25 A˚), and the individual data:fit pairs are put on an
arbitrary y axis to allow for better visualization. Curve ‘‘i’’ shows a comparison of the experimental scattering with calculated scattering from the monovalent
mCSF-1RD1–D3:mCSF-1 structure (PDB code 3EJJ). This binary model lacks significant scattering mass as judged by the gross incompatibility with the lowest
angle experimental data. Curve ‘‘ii’’ illustrates a comparison of the experimental scattering with calculated scattering from a bivalent model derived from the
mCSF-1RD1–D3:mCSF-1 structure (PDB code 3EJJ) in which an additional CSF-1RD1–D3 arm was generated by applying a pure 2-fold symmetry operation about
the ligand dimer interface (circled). Curve ‘‘iii’’ shows rigid-body optimized fit of the bivalent CSF-1RD1–D3:CSF-1 complex with specified CSF-1:CSF-1RD2 core
contacts and moving domains D1 and D3. The upper insets show the calculated distance distribution function for the modeled ternary complexes (blue or green)
and for PDBid 3EJJ (red), and their fits with the experimental function (black). The lower insets display the experimental Guinier region (black) and the calculated
Guinier region of the rigid-body refined ternary models (blue or green) and the binary PDBid 3EJJmodel (red). The shaded area indicates the range of fitting forRG
analysis (RG$S% 1.3).
See also Figure S2 and Table S2.
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Assembly Principles of CSF-1R Ectodomain Complexes16/60 Superdex 75 column (GE Healthcare). To remove the N-terminal His
tag, h/mCSF-1 was subsequently incubated overnight at room temperature
with 1 U of biotinylated thrombin (Novagen) per milligram of h/mCSF-1.
Proteolytic cleavage was monitored by SDS-PAGE. Biotinylated thrombin
was removed using a streptavidin-agarose column (Novagen). Thrombin-
treated h/mCSF-1 was purified using a Source 30Q anion-exchange resin,
followed by gel filtration chromatography on a Superdex-75 column (GE
Healthcare). The fractions corresponding to h/mCSF-1 were pooled and
used for further experiments.
Recombinant glycosylated human and murine CSF-1R ectodomain variants
were produced in transiently transfected HEK293T cells in the presence of
kifunensine based on established protocols (Aricescu et al., 2006; Chang
et al., 2007; Verstraete et al., 2011a). The recombinant CSF-1R ectodomains
carried a C-terminal 6xHis tag. h/mCSF-1R was purified by affinity chromatog-
raphy from the supernatant using a Talon FF column (Clontech). The eluted
fractions containing the purified protein were subsequently injected onto
a Prep-Grade HiLoad 16/60 Superdex 200 column (GE Healthcare). The
fractions corresponding to h/mCSF-1R were pooled and used for further
experiments.
Human and murine CSF-1RD1–D5:CSF-1 and CSF-1RD1–D3:CSF-1 com-
plexes were isolated by gel filtration chromatography on Superdex-200
column (GE Healthcare) after incubation of CSF-1R ectodomains with excess
molar amounts of purified cognate CSF-1.
MALLS
The molecular masses of CSF-1, CSF-1R, and the CSF-1R:CSF-1 complexes
were determined by MALLS. Protein sample was injected into a HPLC-driven
(Shimadzu) FFF module (Wyatt Technology) equilibrated with a 20 mMHEPES
(pH 7.5), 150 mM NaCl running buffer. The FFF module was coupled to an
online UV detector (Shimadzu), an 18-angle light scattering detector (DAWN
HELEOS), and a refractive index detector (Optilab T-rEX) (Wyatt Technology).
Typical concentrations used were 1–10 mM of protein species. A RI increment
value (dn/dc value) of 0.185 ml/g was used for the protein concentration and
molecular mass determination. FFF cross-flows were varied to optimize the
resolution of separation. Data analysis was carried out using the ASTRA V
software.
EM
For preparation of negatively stained hCSF-1RD1–D5:hCSF-1 complex, purified
sample at 0.2 mg/ml in PBS was applied to the clear side of carbon on
a carbon-mica interface and stained with 2% (w/v) uranyl acetate. Images
were recorded under low-dose conditions with a JEOL 1200 EX II microscope
at 100 kV and at a nominal 40.0003 magnification. Selected negatives were
digitized on a Zeiss scanner (Photoscan TD) to a pixel size of 3.5 A˚ at the spec-
imen level. Image processing was carried out using the boxer routine from the
EMAN software package (Ludtke et al., 1999) for particle selection, CTFFIND3
(Mindell and Grigorieff, 2003) for contrast transfer function determination, bctf
from the bsoft package (Heymann et al., 2008) for CTF correction, Imagic (van
Heel et al., 1996) for MSA, classification, and angular reconstitution, and
Spider (Shaikh et al., 2008) for projection matching. UROX (Siebert and Nav-
aza, 2009) was used for structure fitting.
A generous semiautomatic particle selection with the EMAN boxer routine
led to the extraction of a total of 18,432 individual particle subframes of
80 3 80 pixels that were corrected with respect to the contrast transfer func-
tion, and low-path filtered at 15 A˚ resolution. The data set was translationally
aligned relative to the rotationally averaged total sum of the individual images.
The aligned data set was subjected to MSA, which suggested the presence of
a 2-fold symmetry axis. Characteristic class averages were used as a set of
references for multi-reference alignment (MRA) followed by MSA and classifi-
cation. After several iterations, representative class averages were selected to
generate a crude initial model of the hCSF-1RD1–D5:hCSF-1 complex by
angular reconstitution in C2 symmetry. Iterative projection matching of the
model led to a 3D reconstruction with a well-defined global core correspond-
ing to the ligand and hCSF-1RD2-D5, and a protruding weak density cloud,
which we interpreted as D1 linked via a flexible linker to D2 in the complex
core. To isolate a population of hCSF-1R1RD2-D5:hCSF-1 particles with
a better-defined orientation for D1, a set of models with the same core fitting
the EM envelope, but different orientations of D1 protruding into the weak1770 Structure 19, 1762–1772, December 7, 2011 ª2011 Elsevier Ltddensity cloud, was created based on the mCSF-1R1RD1–D3-mCSF-1 crystal
structure (Chen et al., 2008). These models were converted into EM density
and averaged together, which reinforced the density of the core in comparison
to D1, thus supporting the notion that D1 is flexible. The average model was
used for more rounds of projection matching, which allowed a better definition
for the position of D1. A total of 9,421 particles were included in the final recon-
struction, which approached 23 A˚ resolution as estimated via Fourier shell
correlation (FSC) according to the 0.5 criterion.
Modeling of the hCSF-1RD1–D5:hCSF-1 Complex
into the EM Envelope
A homology model for hCSF-1RD1–D5 based on PDB entry 2E9W (Yuzawa
et al., 2007) was fit into the 3D envelopes from EM with the EMAP module
(Wu et al., 2003) of the CHARMM (Brooks et al., 2009) package to generate
initial positions of the complex. A self-guided Langevin dynamics (Wu and
Brooks, 2003) simulation of 1,000 ps was performed, including an implicit
solvation model, to search the conformational space to reach the conforma-
tions satisfying the EMmap constraints. The final conformation wasminimized
with constraints to maintain the C2 symmetry.
SAXS
Data were collected at beamlines X33 of the EMBL at DESY (Hamburg) and
ID14-3 at ESRF (Grenoble) using a robotic sample changer (Roessle et al.,
2008). The measurements were carried out at 298 K, within a momentum
transfer range of 0.01 A˚1 < s < 0.6 A˚1, where s = 4psin(q)/l, and 2q is the
scattering angle. All samples were measured at solute concentrations ranging
from 0.5 to 10.0 mg/ml in 50mMNaPO4 (pH 7.40), 100mMNaCl, with intermit-
tent buffer solution (50 mM NaPO4 [pH 7.40], 100 mM NaCl), and the radiation
damage was monitored using standard procedures. The data were processed
and extrapolated to infinite dilution, and the Guinier region was inspected
using the program PRIMUS (Konarev et al., 2003). The radius of gyration
(Rg), the forward scattering (I(0)), the maximum particle dimension (Dmax),
and the distance distribution function (p(r)) were evaluated using GNOM (Sver-
gun, 1992). The molecular masses of the different constructs were calculated
by comparison with the reference bovine serum albumin (BSA) samples. DAM-
MIN (Svergun, 1999) and AUTOPOROD were used to obtain the excluded
volume and Porod volume of the particles, respectively. GASBOR (Svergun
et al., 2001) was used to obtain the higher resolution ab initio bead models
for the unliganded hCSF-1RD1–D5; 15 independent runs with an average NSD
value of 2.3 were structurally aligned and averaged with DAMAVER (Volkov
and Svergun, 2003). X-ray scattering patterns from structural models were
calculated using the program CRYSOL (Svergun et al., 1995). Constrained
rigid-body refinement of the h/mCSF-1RD1–D3:h/mCSF-1 complexes was
carried out in SASREF7 (Petoukhov and Svergun, 2005) with imposed P2
symmetry and specified CSF-1:CSF-1RD2 contacts. Constrained rigid-body
refinement of the hCSF-1RD1–D5:hCSF-1 complex was carried out in SASREF7
with imposed P2 symmetry, specified CSF-1:CSF-1RD2 contacts, and ambig-
uous contact distances for the D4-D40 interface. Constrained rigid-body
refinement of the unliganded receptor was carried out in P1 symmetry, and
refinement convergence was optimal upon definition of ambiguous distance
contacts at the D4-D40 interface.
ITC
Calorimetric measurements were carried out using purified h/mCSF-1 and
h/mCSF-1R samples dialyzed exhaustively against 20 mM HEPES (pH 7.5),
150 mMNaCl. Experiments were carried out using a VP-ITC MicroCalorimeter
at 310 K, and data were analyzed using the Origin ITC analysis software
package. Titrations were always preceded by an initial injection of 3 ml and
were carried out using 10 ml injections applied 300 s apart, with continuous stir-
ring. The data were fit to the ‘‘one binding site model,’’ and apparent molar
reaction enthalpy (DH), apparent entropy (DS), association constant (KA),
and stoichiometry of binding (N) were determined. Several titrations were per-
formed to evaluate reproducibility.
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The EM map for the 3D reconstruction of the hCSF-1RD1–D5:hCSF-1 complex
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